Lefamulin (Xenleta) for Community Acquired Bacterial Pneumonia
January 21, 2020
Lefamulin was approved by the FDA in August 2019 for the treatment of CABP.
clinical
Sunosi for Excessive Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea
January 20, 2020
Solriamfetol (Sunosi, Jazz Pharmaceuticals) to treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea was approved on March 20, 2019.
FDA OKs Cardiovascular Risk Reduction Indication for Semaglutide
January 17, 2020
The FDA has approved semaglutide (Ozempic, Novo Nordisk) for the reduction of major adverse cardiovascular (CV) events in patients with type 2 diabetes and established CV disease.
What Pharmacists Need to Know About Psoriasis Medications
January 17, 2020
Pharmacists can play an integral role in managing patients with psoriasis through medication therapies and lifestyle modifications.
Diabetes a Serious Risk Factor for Herpes Zoster
January 15, 2020
Shingles vaccination recommended by CDC and ADCES.
Effect of Long-Term Antipsychotic Use on Morbidity, Mortality Risk
January 14, 2020
Antipsychotics were not associated with an increased risk of morbidity and mortality in patients with schizophrenia in a new study.
Most Valuable Drugs in the 2020 Pipeline
January 13, 2020
Here are the top drugs expected to be approved this year.
Cardiovascular Disease Linked to Increased Risk of Kidney Failure
January 10, 2020
Individuals with a history of heart disease may be at an increased risk of developing kidney failure.
WHO Insulin Prequalification Program to Expand Access
January 9, 2020
As the price of insulin has skyrocketed, patients with diabetes are struggling to pay for their medication.
Cancer Mortality Continues Decline, Progress Driven by New Treatments
January 8, 2020
Overall cancer death rates declined by 29% over a 26-year time period, with the largest single-year drop on record reported from 2016 to 2017.
